Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4236 results

Sort By:

Light and Sleep Fragmentation

Study ID: NCT06009289
Start Date: 2026-06-01
End Date: 2028-05-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

120

Intervention / Treatment

Light therapy

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures

Study ID: NCT06579989
Start Date: 2026-01
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Ultrasound for cough

Ultrasound for vocal fold atrophy or vocal fold paresis/paralysis

Ultrasound for dysphagia

Ultrasound for dysphonia

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Lung Protective Ventilation and Driving Pressure Guided PEEP Titration in CABG Surgery

Study ID: NCT07044089
Start Date: 2025-08-01
End Date: 2027-09-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

86

Intervention / Treatment
Sponsor

Kocaeli University

Source: clinicaltrials.gov

Share:
Add to list

COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer

Study ID: NCT06790589
Start Date: 2025-12
End Date: 2030-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

Levothyroxine Oral Tablet [Synthroid]

Sponsor

AHS Cancer Control Alberta

Source: clinicaltrials.gov

Share:
Add to list

Effects of a Mobile App-Based Mindfulness Intervention in Persons with Spinal Cord Injury and Chronic Pain

Study ID: NCT06891989
Start Date: 2026-01-01
End Date: 2029-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

282

Intervention / Treatment

Mindfulness meditation (MM) Intervention

Health Education Active Control Intervention

Sponsor

The University of Texas Health Science Center, Houston

Source: clinicaltrials.gov

Share:
Add to list

Measuring Fluid Flow in the Brain Using Alcohol and MRI in Healthy Participants

Study ID: NCT04608292
Start Date: 2026-01
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Single-voxel MRS

Multi-voxel MRSI

Magnetization Transfer Imaging

Alcohol ingestion

ClearMate

Blood sampling

Sponsor

Sunnybrook Health Sciences Centre

Source: clinicaltrials.gov

Share:
Add to list

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Sacituzumab Govitecan Alone in the Treatment of Advanced Urothelial Cancer

Study ID: NCT06524544
Start Date: 2025-08-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

384

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Pembrolizumab

Administration questionnaire

Sacituzumab Govitan

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma

Study ID: NCT06997081
Start Date: 2025-08-01
End Date: 2030-08-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

104

Intervention / Treatment

Lenalidomide

Dexamethasone

Follower

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

CBT-CP for Veterans With SMI

Study ID: NCT06758414
Start Date: 2025-10-01
End Date: 2029-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

190

Intervention / Treatment

Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)

Health & Wellness (H&W)

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

M-2018-334 in Hematological Malignancies

Study ID: NCT06225050
Start Date: 2025-10-31
End Date: 2028-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

18

Intervention / Treatment

CliniMACS Prodigy® LP-TCRα/β-19-45RA (Trial Version)

Sponsor

Miltenyi Biomedicine GmbH

Source: clinicaltrials.gov

Share:
Add to list